拉沙热

World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for front-line health workers. Feb 2016 [internet publication].全文

1. Hartnett JN, Boisen ML, Oottamasathien D, et al. Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever. Future Virol. 2015;10:559-84.

2. World Health Organization. Lassa fever: fact sheet. Jul 2017 [internet publication].全文

3. Monson MH, Cole AK, Frame JD, et al. Pediatric Lassa fever: a review of 33 Liberian cases. Am J Trop Med Hyg. 1987;36:408-15. 摘要

4. McCormick JB, King IJ, Webb PA, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987;155:445-55. 摘要

5. Price ME, Fisher-Hoch SP, Craven RB, et al. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ. 1988;297:584-7.全文  摘要

6. Cummins D, McCormick JB, Bennett D, et al. Acute sensorineural deafness in Lassa fever. JAMA. 1990;264:2093-6. 摘要

7. Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003;327:1271-5.全文  摘要

8. UK Health Security Agency. Lassa fever: origins, reservoirs, transmission and guidelines. Feb 2022 [internet publication].全文

9. Centers for Disease Control and Prevention. Fact sheet: Lassa fever. Mar 2019 [internet publication].全文

10. Duvignaud A, Jaspard M, Etafo IC, et al. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study. Lancet Glob Health. 2021 Apr;9(4):e469-78.全文  摘要

11. World Health Organization. Disease outbreak news. Lassa fever - Guinea. May 2022 [internet publication].全文

12. Shaffer JG, Grant DS, Schieffelin JS, et al. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis. 2014;8:e2748.全文  摘要

13. World Health Organization. Disease outbreak news. Lassa Fever – United Kingdom of Great Britain and Northern Ireland. Feb 2022 [internet publication].全文

14. Ehlkes L, George M, Samosny G, et al. Management of a Lassa fever outbreak, Rhineland-Palatinate, Germany, 2016. Euro Surveill. 2017 Sep;22(39).全文  摘要

15. World Health Organization. Disease outbreak news. Lassa Fever – The Netherlands (ex –Sierra Leone). Nov 2019 [internet publication].全文

16. Centers for Disease Control and Prevention. Viral hemorrhagic fevers: arenaviruses (arenaviridae). Sep 2021 [internet publication].全文

17. Yun NE, Walker DH. Pathogenesis of Lassa fever. Viruses. 2012;4:2031-48.全文  摘要

18. Eze KC, Salami TA, Kpolugbo JU. Acute abdominal pain in patients with Lassa fever: radiological assessment and diagnostic challenges. Niger Med J. 2014;55:195-200.全文  摘要

19. Mahanty S, Bausch DG, Thomas RL, et al. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis. 2001;183:1713-21.全文  摘要

20. Johnson KM, McCormick JB, Webb PA, et al. Clinical virology of Lassa fever in hospitalized patients. J Infect Dis. 1987;155:456-64. 摘要

21. Monath TP, Newhouse VF, Kemp GE, et al. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science. 1974;185:263-5. 摘要

22. Ter Meulen J, Lukashevich I, Sidibe K, et al. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg. 1996;55:661-6. 摘要

23. ClinicalTrials.gov. A trial to evaluate the optimal dose of MV-LASV (V182-001). ClinicalTrials.gov identifier: NCT04055454. Jan 2022 [internet publication].全文

24. ClinicalTrials.gov. A clinical trial to evaluate the safety and immunogenicity of rVSV∆G-LASV-GPC vaccine in adults in good general health. ClinicalTrials.gov identifier: NCT04794218. Nov 2021 [internet publication].全文

25. Lunkenheimer K, Hufert FT, Schmitz H. Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol. 1990;28:2689-92.全文  摘要

26. Fisher-Hoch SP, Tomori O, Nasidi A, et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ. 1995;311:857-9.全文  摘要

27. Monath TP, Mertens PE, Patton R, et al. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg. 1973;22:773-9. 摘要

28. Haas WH, Breuer T, Pfaff G, et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis. 2003;36:1254-8.全文  摘要

29. Fisher-Hoch SP, Price ME, Craven RB, et al. Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet. 1985;2:1227-9. 摘要

30. Günther S, Weisner B, Roth A, et al. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis. 2001;184:345-9.全文  摘要

31. Dongo AE, Kesieme EB, Iyamu CE, et al. Lassa fever presenting as acute abdomen: a case series. Virol J. 2013;10:123.全文  摘要

32. Bausch DG, Rollin PE, Demby AH, et al. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol. 2000;38:2670-7.全文  摘要

33. Fisher-Hoch S, McCormick JB, Sasso D, et al. Hematologic dysfunction in Lassa fever. J Med Virol. 1988;26:127-35. 摘要

34. McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314:20-6. 摘要

35. Schmitz H, Köhler B, Laue T, et al. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect. 2002;4:43-50. 摘要

36. Boggild AK, Esposito DH, Kozarsky PE, et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med. 2015;162:757-64.全文  摘要

37. World Health Organization. WHO recommended surveillance standards. Second edition. Feb 1999 [internet publication].全文

38. Bausch DG, Hadi CM, Khan SH, et al. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis. 2010;51:1435-41.全文  摘要

39. World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for front-line health workers. Feb 2016 [internet publication].全文

40. Cross RW, Mire CE, Branco LM, et al. Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. Antiviral Res. 2016;133:218-22.全文  摘要

41. Oestereich L, Rieger T, Lüdtke A, et al. Efficacy of favipiravir alone and in combination with ribavirin in a lethal, immunocompetent mouse model of Lassa fever. J Infect Dis. 2016;213:934-8.全文  摘要

42. ClinicalTrials.gov. Pharmacokinetics, tolerability and safety of favipiravir compared to ribavirin for the treatment of Lassa fever (SAFARI). ClinicalTrials.gov identifier: NCT04907682. Jul 2022 [internet publication].全文

43. ClinicalTrials.gov. Multiple ascending oral dose 14-day trial of LHF-535 in healthy participants. ClinicalTrials.gov identifier: NCT03993704. Jul 2020 [internet publication].全文

44. Buba MI, Dalhat MM, Nguku PM, et al. Mortality among confirmed Lassa fever cases during the 2015-2016 outbreak in Nigeria. Am J Public Health. 2017 Dec 21:e1-e3.全文  摘要

45. Liao BS, Byl FM, Adour KK. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause. Otolaryngol Head Neck Surg. 1992;106:226-9. 摘要

46. Solbrig MV, McCormick JB. Lassa fever: central nervous system manifestations. J Trop Geogr Neurol. 1991;1:23-30.

47. Hirabayashi Y, Oka S, Goto H, et al. An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis. 1988;158:872-5. 摘要